Open AccessNational Antiviral Treatment Program and the Incidence of Hepatocellular Carcinoma and Associated Mortality in Taiwan
Author(s) -
ChiaHsuin Chang,
JouWei Lin,
LiChiu Wu,
ChiaHong Liu,
MeiShu Lai
Publication year - 2013
Publication title -
medical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.632
H-Index - 178
eISSN - 1537-1948
pISSN - 0025-7079
DOI - 10.1097/mlr.0b013e3182a502ba
Subject(s) - hepatocellular carcinoma , incidence (geometry) , medicine , oncology , carcinoma , medline , intensive care medicine , biology , physics , optics , biochemistry
Taiwan's Bureau of National Health Insurance launched the National Antiviral Treatment Program (NATP) in 2003 to reimburse patients for antiviral drugs and interferons for chronic hepatitis B and C. The objective was to examine the impact of the NATP on the incidence and mortality due to hepatocellular carcinoma (HCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom